Number of shares and votes in Orexo

The number of shares and votes in Orexo AB (STO:ORX) has changed as a
result of the exercise of warrants in connection with the company’s
incentive programs.

Today, the last trading day of the month, there are in total 32,914,908
shares and votes in the company.

About Orexo

Orexo is an emerging specialty pharma company with commercial operations
in the United States and R&D in Sweden developing improved treatments
using proprietary drug delivery technology and commercial operations in
the United States. The company is commercializing its proprietary
product, Zubsolv®, for maintenance treatment of opioid dependence, in
the United States. Zubsolv is a novel formulation of buprenorphine and
naloxone using Orexo’s extensive knowledge in sublingual technologies.
Orexo has a portfolio of two approved and revenue generating products
currently marketed under license in the EU and US. Orexo AB, with its
headquarters in Sweden, is listed on NASDAQ OMX Stockholm Exchange and
its American Depositary Receipts (ADRs) trade on the OTCQX marketplace
in the U.S. under the symbol, “ORXOY”. The largest shareholders are Novo
A/S and HealthCap.